MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis"

  • 2024 International Congress

    Choreoballism due to Bisphosphonate-Induced Antiphospholipid Syndrome: A Case Report

    P. Leistikow, N. Joseph, D. Shah-Zamora (Winston-Salem, USA)

    Objective: To describe a patient who presented with hyperkinetic movements due to zoledronic acid-induced autoimmunity. Background: Chorea is a rare neurologic manifestation of antiphospholipid syndrome…
  • 2024 International Congress

    The clinical features, neuroimagings and outcomes of diabetic striatopathy: a retrospective study at tertiary hospital in Vietnam

    T. Nguyen, N. Nguyen, K. Le, K. Nguyen, T. Tran (Ho Chi Minh, Viet Nam)

    Objective: This study aims to analyze the clinical features, neuroimaging findings, and outcomes of diabetic striatopathy among Vietnamese patients. Background: Diabetic striatopathy (DS) is a…
  • 2024 International Congress

    Fahr’s Disease Presenting as Chorea: A Rare Case Report

    DA. Soraya, A. Tiksnadi, D. Tunjungsari (Malang, Indonesia)

    Objective: Given its rare incidence, there was a limited study reporting Fahr's Disease (FD) presenting as chorea. Background: FD is a rare condition characterized by…
  • 2024 International Congress

    Two Cases of Moyamoya Syndrome-Associated Chorea and Dystonia

    M. Qureshi, S. Radmard (Albany, USA)

    Objective: To report on two cases of mixed movement disorder presentation of chorea and dystonia due to moyamoya syndrome for which one case was successfully…
  • 2024 International Congress

    Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

    A. Kumar, P. Mishra (Delhi, India)

    Objective: Our objective is to estimate the level of Hcy ,vitamin B12 , folic acid with motor and non-motor symptoms in HD patients in school…
  • 2024 International Congress

    Exploring Correlations between Mutant Huntingtin, NfL, and MRI in Huntington’s Disease: A Multimodal Analysis

    J. Pérez, S. Horta, G. Saura, A. Barba, A. Davi, A. Vázquez, E. Rivas, A. Campolongo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: This study aims to investigate correlations between mHtt and NfL levels and MRI findings in individuals at different stages of HD, including presymptomatic and…
  • 2024 International Congress

    Serum urea and clinical outcomes in Huntington’s disease

    O. Makos, J. Badenoch, M. Hartmann, N. Martin, A. Rangel-Cristales, J. Valera-Bermejo, S. Williams, D. van Wamelen (London, United Kingdom)

    Objective: To investigate the relationship between serum urea levels and clinical outcomes in people with Huntington’s disease. Background: Several studies in people with Huntington’s disease…
  • 2024 International Congress

    Measuring Cortisol Levels in Persons with Huntington’s Disease

    A. Clarke, B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess subjective and objective measures of emotional stress via standardized scales and a physiological measure (salivary cortisol) in persons with Huntington’s Disease (HD)…
  • 2024 International Congress

    ​​Deciphering the Huntington’s Disease Research Landscape: A Comprehensive Bibliometric and Trend Analysis

    S. Khankar, T. Lalotra, A. Subhedar, S. Joshi, S. Mast, A. Bhonsale (Nagpur, India)

    Objective: To map the Huntington's Disease research landscape, identifying key trends, gaps, and the most impactful studies to guide future research directions and therapeutic strategies.…
  • 2024 International Congress

    Movement Disorders in Anti-IGLON5 Antibody Disease

    S. Garg, J. Kaur, K. Karan, D. Nanduri (Bengaluru, India)

    Objective: To review demographic, clinical features, treatment trends, and responses in Anti-IgLON5 disease with a focus on movement disorders Background: Anti-IgLON5 antibody disease has emerged…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley